| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.31 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |